LyphoMed Inc said it intends to
file a registration statement with the Securities and Exchange
Commission covering the sale of 70 mln dlrs principal amount of
convertible subordinated debentures.
    Concurrent with the debenture offering, LyphoMed said it
plans to sell an additional 30 mln dlrs of debentures in
Fujisawa Pharmaceutical Co Ltd, which currently owns about 30
pct of the company's common stock.
    It said the offering will be made only by prospectus.
 Reuter
&#3;